- Home
- LBRX vs ARKO Comparison
LBRX vs ARKO Comparison
Compare LBRX & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LBRX | ARKO |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.2M | 520.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | LBRX | ARKO |
|---|---|---|
| Price | $19.89 | $4.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $49.00 | $7.50 |
| AVG Volume (30 Days) | ★ 531.1K | 513.8K |
| Earning Date | 02-15-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $7,887,822,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $40.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.36 | $3.51 |
| 52 Week High | $23.15 | $7.84 |
Technical Indicators
Market Signals| Indicator | LBRX | ARKO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 36.86 |
| Support Level | N/A | $4.39 |
| Resistance Level | N/A | $4.63 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 0.00 | 10.73 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.